Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (91) 91
life sciences & biomedicine (85) 85
science & technology (85) 85
male (68) 68
female (65) 65
middle aged (52) 52
aged (46) 46
cardiovascular system & cardiology (40) 40
biological and medical sciences (38) 38
general & internal medicine (37) 37
medicine, general & internal (36) 36
abridged index medicus (33) 33
cardiac & cardiovascular systems (33) 33
medical sciences (33) 33
cardiovascular diseases (26) 26
treatment outcome (26) 26
cardiology. vascular system (24) 24
cardiovascular disease (24) 24
cardiovascular (23) 23
risk factors (23) 23
adult (22) 22
double-blind method (18) 18
drug therapy (18) 18
stroke (18) 18
coronary heart disease (17) 17
heart (17) 17
hypertension (17) 17
clinical trials (16) 16
follow-up studies (16) 16
heart failure (16) 16
medicin och hälsovetenskap (16) 16
myocardial infarction (16) 16
atrial fibrillation (15) 15
heart attacks (15) 15
mortality (15) 15
aged, 80 and over (14) 14
cardiology (14) 14
care and treatment (14) 14
prevention (14) 14
australia (13) 13
cardiovascular diseases - prevention & control (13) 13
drug therapy, combination (13) 13
stroke - prevention & control (13) 13
blood and lymphatic vessels (12) 12
evidence-based medicine (12) 12
hemorrhage - chemically induced (12) 12
patient outcomes (12) 12
diabetes (11) 11
general aspects (11) 11
patients (11) 11
atrial fibrillation - drug therapy (10) 10
blood pressure (10) 10
dosage and administration (10) 10
peripheral vascular disease (10) 10
arterial hypertension. arterial hypotension (9) 9
cardiovascular diseases - mortality (9) 9
clinical manifestations. epidemiology. investigative techniques. etiology (9) 9
electrocardiography (9) 9
medical and health sciences (9) 9
adolescent (8) 8
cholesterol (8) 8
diabetes mellitus, type 2 - drug therapy (8) 8
incidence (8) 8
medical research (8) 8
platelet aggregation inhibitors - therapeutic use (8) 8
proportional hazards models (8) 8
prospective studies (8) 8
research (8) 8
acute coronary syndrome (7) 7
aspirin - therapeutic use (7) 7
atherosclerosis (7) 7
cerebral infarction (7) 7
diabetes mellitus (7) 7
insulin (7) 7
life sciences (7) 7
time factors (7) 7
usage (7) 7
acute coronary syndromes (6) 6
analysis (6) 6
anticoagulants - administration & dosage (6) 6
anticoagulants - adverse effects (6) 6
anticoagulants - therapeutic use (6) 6
aspirin (6) 6
bleeding (6) 6
cardiac patients (6) 6
cardiovascular diseases - epidemiology (6) 6
clinical outcomes (6) 6
complications and side effects (6) 6
diabetes mellitus, type 2 - complications (6) 6
dose-response relationship, drug (6) 6
echocardiography (6) 6
health aspects (6) 6
heart diseases (6) 6
hemorrhage (6) 6
hypertension - drug therapy (6) 6
hypertension - physiopathology (6) 6
kaplan-meier estimate (6) 6
myocardial infarction - drug therapy (6) 6
platelet aggregation inhibitors - adverse effects (6) 6
randomized controlled trials as topic (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dabigatran versus Warfarin in Patients with Atrial Fibrillation
by Connolly, Stuart J and Ezekowitz, Michael D and Yusuf, Salim and Eikelboom, John and Oldgren, Jonas and Parekh, Amit and Pogue, Janice and Reilly, Paul A and Themeles, Ellison and Varrone, Jeanne and Wang, Susan and Alings, Marco and Xavier, Denis and Zhu, Jun and Diaz, Rafael and Lewis, Basil S and Darius, Harald and Diener, Hans-Christoph and Joyner, Campbell D and Wallentin, Lars and the RE-LY Steering Committee and Investigators and RE-LY Steering Comm & Investigator and RE-LY Steering Committee and Investigators
The New England journal of medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 12, pp. 1139 - 1151
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Cardiac dysrhythmias | Myocardial Infarction - epidemiology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Male | Dyspepsia - chemically induced | Dabigatran | Warfarin - administration & dosage | Warfarin - therapeutic use | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Liver - drug effects | Atrial Fibrillation - mortality | Female | Stroke - epidemiology | Benzimidazoles - adverse effects | Embolism - epidemiology | Stroke - prevention & control | Pyridines - administration & dosage | Double-Blind Method | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Proportional Hazards Models | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Chi-Square Distribution | Aged | Prodrugs - therapeutic use | Hemorrhage - chemically induced | Medical research | Cardiac arrhythmia | Anticoagulants | Cardiovascular disease | Stroke | Drug therapy | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
by Eikelboom, John W and Connolly, Stuart J and Bosch, Jackie and Dagenais, Gilles R and Hart, Robert G and Shestakovska, Olga and Diaz, Rafael and Alings, Marco and Lonn, Eva M and Anand, Sonia S and Widimsky, Petr and Hori, Masatsugu and Avezum, Alvaro and Piegas, Leopoldo S and Branch, Kelley R.H and Probstfield, Jeffrey and Bhatt, Deepak L and Zhu, Jun and Liang, Yan and Maggioni, Aldo P and Lopez-Jaramillo, Patricio and O’Donnell, Martin and Kakkar, Ajay K and Fox, Keith A.A and Parkhomenko, Alexander N and Ertl, Georg and Störk, Stefan and Keltai, Matyas and Ryden, Lars and Pogosova, Nana and Dans, Antonio L and Lanas, Fernando and Commerford, Patrick J and Torp-Pedersen, Christian and Guzik, Tomek J and Verhamme, Peter B and Vinereanu, Dragos and Kim, Jae-Hyung and Tonkin, Andrew M and Lewis, Basil S and Felix, Camilo and Yusoff, Khalid and Steg, P. Gabriel and Metsarinne, Kaj P and Cook Bruns, Nancy and Misselwitz, Frank and Chen, Edmond and Leong, Darryl and Yusuf, Salim and COMPASS Investigators
The New England journal of medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
by Ridker, Paul M and Revkin, James and Amarenco, Pierre and Brunell, Robert and Curto, Madelyn and Civeira, Fernando and Flather, Marcus and Glynn, Robert J and Gregoire, Jean and Jukema, J. Wouter and Karpov, Yuri and Kastelein, John J.P and Koenig, Wolfgang and Lorenzatti, Alberto and Manga, Pravin and Masiukiewicz, Urszula and Miller, Michael and Mosterd, Arend and Murin, Jan and Nicolau, Jose C and Nissen, Steven and Ponikowski, Piotr and Santos, Raul D and Schwartz, Pamela F and Soran, Handrean and White, Harvey and Wright, R. Scott and Vrablik, Michal and Yunis, Carla and Shear, Charles L and Tardif, Jean-Claude and SPIRE Cardiovascular Outcome Inve and ICON and Miller Tanner Associates and Julius Clinical and Acurian and C5 and ICON Analytical Lab and Boston Clinical Res Inst and IMI and COVANCE and SPIRE Cardiovascular Outcome Investigators
The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Injections, Subcutaneous - adverse effects | Proprotein Convertase 9 - immunology | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Anticholesteremic Agents - immunology | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Lipids - blood | Treatment Failure | Antibodies - blood | Cholesterol, LDL - blood | Female | Antibodies, Monoclonal, Humanized - immunology | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Immunoglobulins | Stroke | Risk groups | Clinical trials | Cardiovascular disease | Lipids | Subtilisin | Angina | Low density lipoprotein | Manuscripts | Cholesterol | Disease prevention | Kexin | Monoclonal antibodies | Cardiovascular diseases | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
by Bonaca, Marc P and Bhatt, Deepak L and Cohen, Marc and Steg, Philippe Gabriel and Storey, Robert F and Jensen, Eva C and Magnani, Giulia and Bansilal, Sameer and Fish, M. Polly and Im, Kyungah and Bengtsson, Olof and Ophuis, Ton Oude and Budaj, Andrzej and Theroux, Pierre and Ruda, Mikhail and Hamm, Christian and Goto, Shinya and Spinar, Jindrich and Nicolau, José Carlos and Kiss, Robert G and Murphy, Sabina A and Wiviott, Stephen D and Held, Peter and Braunwald, Eugene and Sabatine, Marc S and PEGASUS-TIMI 54 Steering Comm and PEGASUS-TIMI 54 Steering Committee and Investigators
The New England journal of medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Purinergic P2Y Receptor Antagonists - administration & dosage | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Ticagrelor | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Adenosine - administration & dosage | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Aged | Hemorrhage - chemically induced | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
by Riddle, Matthew C and Bogaty, P and Capozzi, M and Crespo, C and Jeffery, I and Jerums, G and Ettmuller, Y and Mellitzer, K and Steiner, K and Ramanovski, A and Freire, F and Campeau, J and Conway, J and Gould, D and Kirouac, I and Singh, J and Sivucha, W and Li, M and Yao, J and Yu, M and Zheng, B and Llamas, A and Kerum, T and Kajander, O and Malville, E and Enghofer, K and Mueller-Hoff, C and Schumm-Draeger, P and Wuechner-Hofmann, S and Jozsef, I and Badgandi, M and Bloch, L and Ilany, J and Zahger, D and Zimlichman, R and Calcinaro, F and Corona, G and Di Pasquale, G and Sforza, A and Veniani, M and Kim, I and De Mulder, M and Umans, V and Istad, H and Mrowczynska, A and Mytnik, M and Zadrozny, J and Cheta, D and Ausheva, A and Bulkina, O and Gnidkina, N and Kistner, J and Kobalava, Z and Kurbanova, E and Sargsyan, V and Solovyeva, E and Leppert, J and Lysell-Bergstrom, C and Burton, J and Laithwaite, D and Robinson, A and Dudl, J and Nasr, C and Osei, K and Savarese, V and Appiah, M and Strickland, K and Lux, L and Rogan, J and Andersen, I and Tarvainen, M and Roy, P and Kim, J.M and Lim, S and Van de Wetering, A and Jendeberg, A and Jankularova, I and Froberg, M and Luca, S and Troncoso, C and Lai, N and Phillips, J and Andersen, K and Roy, M and Velonas, J and Camargo, S and Bulow, M and Bueschges, G and Kelly-Conroy, M and Platner, N and Didden, E and Van Setten-Van der Meer, L and Von Bannisseht, E.E and Patru, D and Wolf, A and Ashbaugh, R and Brolin, G and Oney, S and Ginsberg, J and Leiby, A and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
by Bogaty, P and Sago, L and Villamil, A and Ho, J and Feinboeck, C and Gulz, E and Carlson, B and Ho, K and Lecours, S and O'Keefe, D and Vizel, S and Zambra, F and Gao, X and Lu, J and Sun, H and Wang, X and Goldoni, V and Christensen, P and Delmas, T and Hadjadj, S and Travert, F and Dornisch, M and Maimer, A and von Amelunxen, S and Wilhelm, B and Szilveszter, D and Rajagopal, R and Rao, P and Siddharth, R and Hussain, T and McGurk, C and Khader, N and Mardi, T and Iannuzzi, G and Kim, B and Cedano-Limon, M and Holwerda, N and Winther, J and Mella, B and Omelanczuk-Wiech, E and Swiatkowski, M and Wiatr, D and Bala, C and Graur, M and Mindrescu, N and Nicodim, S and Jaiani, N and Brice, B and Levitt, N and Donnelly, R and Fox, C and McNally, P and Millar-Craig, M and Alam, A and Bethel, M and De Bold, C and Licata, A and Madden, M and McFarlane, S and Schnure, J and Carrillo, E and Marante, D and Augensen, N and Bollero, G and Pascual, A and Hagerimana, A and Osachoff, J and Miočević, V.V and Guillarme, C and Lenz, T and Leptich, A and Park, J.S and Song, Y and Castano, B and Lenehan, A and Olmi, M and Flavel, Flavel and Long, A and McNamara, K and Kivioja, P and Freitas, E and Osório, R and Ullyatt, L and Arau, M and Borre Hansen, A and Coudret, S and Tenne, N and Inhoffen, C and Krueger, H and Wagner, E and Poongothai, S and Rood, P and Winge, A and Tamondong, A and Vitug, L and Ismael, F and van Wyngaard, G and Viaplana, J and Backlund, M and Tavlayan, S and The ORIGIN Trial Investigators and ORIGIN Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
by Scirica, Benjamin M and Bhatt, Deepak L and Braunwald, Eugene and Steg, P. Gabriel and Davidson, Jaime and Hirshberg, Boaz and Ohman, Peter and Frederich, Robert and Wiviott, Stephen D and Hoffman, Elaine B and Cavender, Matthew A and Udell, Jacob A and Desai, Nihar R and Mosenzon, Ofri and McGuire, Darren K and Ray, Kausik K and Leiter, Lawrence A and Raz, Itamar and Savor-Timi Steering Comm Investig and SAVOR-TIMI 53 Steering Committee and Investigators
The New England journal of medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives |